| Primary |
| Hiv Infection |
31.8% |
| Chest Pain |
9.1% |
| Hepatitis C |
9.1% |
| Asthma |
4.5% |
| Bone Density Decreased |
4.5% |
| Depression |
4.5% |
| Dyspepsia |
4.5% |
| Gastrooesophageal Reflux Disease |
4.5% |
| Glioblastoma Multiforme |
4.5% |
| Herpes Virus Infection |
4.5% |
| Hypertension |
4.5% |
| Hypothyroidism |
4.5% |
| Ischaemic Heart Disease Prophylaxis |
4.5% |
| Nausea |
4.5% |
|
| Blood Creatinine Increased |
16.7% |
| Drug Interaction |
16.7% |
| Genital Herpes |
16.7% |
| Medication Error |
16.7% |
| Overdose |
16.7% |
| Vision Blurred |
16.7% |
|
| Secondary |
| Product Used For Unknown Indication |
43.3% |
| Myocardial Infarction |
7.4% |
| Percutaneous Coronary Intervention |
6.9% |
| Hiv Infection |
3.9% |
| Rheumatoid Arthritis |
3.9% |
| Depression |
3.0% |
| Foetal Exposure During Pregnancy |
3.0% |
| Hypertension |
3.0% |
| Liver Transplant |
2.6% |
| Psoriasis |
2.6% |
| Blood Pressure Abnormal |
2.2% |
| Contraception |
2.2% |
| Fibromyalgia |
2.2% |
| Immunosuppressant Drug Therapy |
2.2% |
| Migraine |
2.2% |
| Pain |
2.2% |
| Parkinson's Disease |
2.2% |
| Abdominal Pain Upper |
1.7% |
| Bone Marrow Conditioning Regimen |
1.7% |
| Chest Pain |
1.7% |
|
| Pain |
8.7% |
| Drug Ineffective |
6.5% |
| Rash |
6.5% |
| Toxicity To Various Agents |
6.5% |
| Unevaluable Event |
6.5% |
| Weight Decreased |
6.5% |
| Death |
4.3% |
| Drug Interaction |
4.3% |
| Intestinal Ulcer |
4.3% |
| Myocardial Infarction |
4.3% |
| Pharyngeal Oedema |
4.3% |
| Presyncope |
4.3% |
| Sepsis |
4.3% |
| Substance Abuse |
4.3% |
| Syncope |
4.3% |
| Thrombosis In Device |
4.3% |
| Vomiting |
4.3% |
| Weight Increased |
4.3% |
| White Blood Cell Count Decreased |
4.3% |
| Adverse Drug Reaction |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
14.4% |
| Hypertension |
14.0% |
| Blood Cholesterol Increased |
7.4% |
| Gastrooesophageal Reflux Disease |
5.8% |
| Bipolar Disorder |
5.4% |
| Pain |
5.1% |
| Anxiety |
4.3% |
| Drug Use For Unknown Indication |
4.3% |
| Breast Cancer |
3.9% |
| Depression |
3.9% |
| Diabetes Mellitus |
3.9% |
| Schizophrenia |
3.9% |
| Asthma |
3.5% |
| Hypercholesterolaemia |
3.5% |
| Insomnia |
3.1% |
| Premedication |
3.1% |
| Attention Deficit/hyperactivity Disorder |
2.7% |
| Blood Pressure |
2.7% |
| Hypothyroidism |
2.7% |
| Multiple Sclerosis |
2.3% |
|
| Urticaria |
8.3% |
| Weight Decreased |
6.9% |
| Wrong Technique In Drug Usage Process |
6.9% |
| Drug Ineffective |
5.6% |
| Intentional Drug Misuse |
5.6% |
| Myocardial Infarction |
5.6% |
| Pain In Extremity |
5.6% |
| Tardive Dyskinesia |
5.6% |
| Weight Increased |
5.6% |
| Depression |
4.2% |
| Gastrooesophageal Reflux Disease |
4.2% |
| Hypersensitivity |
4.2% |
| Ischaemic Stroke |
4.2% |
| Malaise |
4.2% |
| Off Label Use |
4.2% |
| Pancreatitis |
4.2% |
| Prostate Cancer |
4.2% |
| Pyrexia |
4.2% |
| Type 1 Diabetes Mellitus |
4.2% |
| Acute Myeloid Leukaemia |
2.8% |
|
| Interacting |
| Cardiac Disorder |
20.8% |
| Depression |
14.6% |
| Pain |
12.5% |
| Gastrooesophageal Reflux Disease |
10.4% |
| Product Used For Unknown Indication |
8.3% |
| Ulcer |
8.3% |
| Abdominal Discomfort |
6.3% |
| Anxiety |
4.2% |
| Muscle Spasms |
4.2% |
| Post-traumatic Stress Disorder |
4.2% |
| Sleep Disorder |
4.2% |
| Hypothyroidism |
2.1% |
|
| Drug Interaction |
60.0% |
| Abdominal Discomfort |
10.0% |
| Hearing Impaired |
10.0% |
| Mental Impairment |
10.0% |
| Weight Decreased |
10.0% |
|
